martes, 21 de abril de 2020

FDA approves pill for aggressive breast cancer that’s spread in the body - STAT

FDA approves pill for aggressive breast cancer that’s spread in the body - STAT

Cancer Briefing

FDA approves pill for aggressive breast cancer that’s spread in the body

By ASSOCIATED PRESS


NIH
The FDA said the twice-daily pill is for people with what’s known as HER2-positive breast cancer that has spread and resisted multiple other medicines.

No hay comentarios:

Publicar un comentario